Virtus ETF Advisers LLC Editas Medicine, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 16,790 shares of EDIT stock, worth $23,170. This represents 0.03% of its overall portfolio holdings.

Number of Shares

16,790

Previous 16,489 1.83%

Holding current value

$23,170

Previous $77,000 25.97%

% of portfolio

0.03%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.39 - $5.96 $1,020 - $1,793	301 Added 1.83%	16,790 $57,000
Q2 2024 Aug 14, 2024	BUY	$4.67 - $7.28 $39,690 - $61,872	8,499 Added 106.37%	16,489 $77,000
Q1 2024 May 15, 2024	SELL	$7.03 - $11.07 $3,873 - $6,099	-551 Reduced 6.45%	7,990 $59,000
Q4 2023 Feb 15, 2024	SELL	$6.25 - $11.11 $2,331 - $4,144	-373 Reduced 4.18%	8,541 $86,000
Q3 2023 Nov 07, 2023	SELL	$6.92 - $9.31 $6,165 - $8,295	-891 Reduced 9.09%	8,914 $69,000
Q2 2023 Aug 14, 2023	BUY	$6.36 - $11.47 $228 - $412	36 Added 0.37%	9,805 $80,000
Q1 2023 May 15, 2023	SELL	$7.03 - $11.53 $26,369 - $43,249	-3,751 Reduced 27.74%	9,769 $70,000
Q4 2022 Feb 14, 2023	BUY	$8.32 - $13.21 $25,625 - $40,686	3,080 Added 29.5%	13,520 $119,000
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $851 - $1,359	70 Added 0.68%	10,440 $128,000
Q2 2022 Aug 12, 2022	BUY	$9.99 - $21.35 $49,400 - $105,575	4,945 Added 91.15%	10,370 $123,000
Q1 2022 May 16, 2022	SELL	$14.08 - $27.63 $4,435 - $8,703	-315 Reduced 5.49%	5,425 $103,000
Q4 2021 Feb 14, 2022	BUY	$26.55 - $40.57 $5,894 - $9,006	222 Added 4.02%	5,740 $152,000
Q3 2021 Nov 15, 2021	SELL	$39.27 - $72.94 $11,309 - $21,006	-288 Reduced 4.96%	5,518 $227,000
Q2 2021 Aug 10, 2021	BUY	$31.29 - $56.64 $28,849 - $52,222	922 Added 18.88%	5,806 $329,000
Q1 2021 May 17, 2021	BUY	$39.71 - $90.58 $3,415 - $7,789	86 Added 1.79%	4,884 $205,000
Q4 2020 Feb 12, 2021	SELL	$27.07 - $84.35 $179,176 - $558,312	-6,619 Reduced 57.97%	4,798 $336,000
Q3 2020 Nov 13, 2020	SELL	$28.06 - $37.16 $44,054 - $58,341	-1,570 Reduced 12.09%	11,417 $320,000
Q2 2020 Aug 05, 2020	BUY	$18.5 - $34.34 $240,259 - $445,973	12,987 New	12,987 $384,000

Others Institutions Holding EDIT

# of Institutions

250

Shares Held

56.9M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $94.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Editas Medicine, Inc. Transaction History